Summary:
- Drs. Emmanuelle Charpentier and Jennifer Doudna were awarded the $3 million Breakthrough Prize in Life Sciences for their pioneering work on CRISPR gene-editing technology.
- Their research led to the development of the first CRISPR-based therapy for sickle cell disease, a genetic disorder that affects red blood cells.
- CRISPR is a powerful tool that allows scientists to precisely edit DNA, opening up new possibilities for treating genetic diseases and other medical applications.